UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

Nature chemical biology, 2013-09, Vol.9 (9), p.548-556

2013

Volltextzugriff (PDF)

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury

Molecular cancer therapeutics, 2018-03, Vol.17 (3), p.603-613

2018

Volltextzugriff (PDF)

Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers

Experimental cell research, 2015-03, Vol.332 (2), p.267-277

2015

Volltextzugriff (PDF)

Establishment and genomic characterization of the new chordoma cell line Chor-IN-1

Scientific reports, 2017-08, Vol.7 (1), p.9226-14, Article 9226

2017

Volltextzugriff (PDF)

Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

Clinical cancer research, 2007-10, Vol.13 (19), p.5942-5951

2007

Volltextzugriff (PDF)

Cdc7 Kinase Inhibitors: 5-Heteroaryl-3-Carboxamido-2-Aryl Pyrroles as Potential Antitumor Agents. 1. Lead Finding

Journal of medicinal chemistry, 2010-10, Vol.53 (20), p.7296-7315

2010

Volltextzugriff (PDF)

Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)

Bioorganic & medicinal chemistry letters, 2009-06, Vol.19 (11), p.2924-2927

2009

Volltextzugriff (PDF)

Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Molecular cancer therapeutics, 2016-04, Vol.15 (4), p.628-639

2016

Volltextzugriff (PDF)

High-content analysis of kinase activity in cells

Combinatorial chemistry & high throughput screening, 2008-08, Vol.11 (7), p.523-536

2008

Volltextzugriff (PDF)

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 2016-01, Vol.108 (1), p.1

2016

Volltextzugriff (PDF)

Phase II study on safety and efficacy of NMS-01940153E, an MPS1 inhibitor with first-in-class potential, in adult patients with unresectable hepatocellular carcinoma (HCC) previously treated with systemic therapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4185-TPS4185

2023

Volltextzugriff (PDF)

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

British journal of cancer, 2015-12, Vol.113 (12), p.1730-1734

2015

Volltextzugriff (PDF)

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24), p.10255-10264

2010

Volltextzugriff (PDF)

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

European journal of cell biology, 2009-12, Vol.88 (12), p.779-785

2009

Volltextzugriff (PDF)

Abstract 4843: NMS-P293, a PARP-1 selective inhibitor with no trapping activity and high CNS penetration, possesses potent in vivo efficacy and represents a novel therapeutic option for brain localized metastases and glioblastoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4843-4843

2018

Volltextzugriff (PDF)

Stereoselective synthesis of 3,4‐dihydropyrrolo[1,2‐a]pyrazin‐1(2H)‐one derivatives as PIM kinase inhibitors inspired from marine alkaloids

Chirality (New York, N.Y.), 2022-11, Vol.34 (11), p.1437-1452

2022

Volltextzugriff (PDF)

Stereoselective synthesis of 3,4‐dihydropyrrolopyrazin‐1(2H)‐one derivatives as PIM kinase inhibitors inspired from marine alkaloids

Chirality (New York, N.Y.), 2022-11, Vol.34 (11), p.1437-1452

2022

Volltextzugriff (PDF)

NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.1006-1016

2012

Volltextzugriff (PDF)

Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure–Activity Relationships

Journal of medicinal chemistry, 2013-01, Vol.56 (2), p.437-450

2013

Volltextzugriff (PDF)

Identification of unprecedented ATP-competitive choline kinase inhibitors

Bioorganic & medicinal chemistry letters, 2021-11, Vol.51, p.128310-128310, Article 128310

2021

Volltextzugriff (PDF)

Abstract 1324: NMS-P088, a novel FLT3, KIT and CSF1R inhibitor, is a promising clinical candidate for AML and CMML treatment

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1324-1324

2019

Volltextzugriff (PDF)

Multiparametric cell cycle analysis by automated microscopy

Journal of biomolecular screening, 2006-09, Vol.11 (6), p.586-598

2006

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(93)
Dissertationen
(1)

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(42)
Humans
(38)
Cell Line, Tumor
(20)
Pharmacology & Pharmacy
(20)
Animals
(19)
Antineoplastic Agents - Pharmacology
(19)
Chemistry, Medicinal
(16)
Oncology
(16)
Mice
(15)
Chemistry
(13)
Physical Sciences
(12)
Cell Proliferation - Drug Effects
(11)
Structure-Activity Relationship
(11)
Antineoplastic Agents - Chemistry
(10)
Protein Kinase Inhibitors - Pharmacology
(10)
Biochemistry & Molecular Biology
(9)
Chemistry, Organic
(9)
Mice, Nude
(9)
Female
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of Entrectinib: A New 3‑Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c‑ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury

Discovery of 2‑[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro‑1H‑isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP‑1 Inhibitor for Cancer Therapy

Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers

Establishment and genomic characterization of the new chordoma cell line Chor-IN-1

Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

Cdc7 Kinase Inhibitors: 5-Heteroaryl-3-Carboxamido-2-Aryl Pyrroles as Potential Antitumor Agents. 1. Lead Finding

Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)

Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

High-content analysis of kinase activity in cells

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

Phase II study on safety and efficacy of NMS-01940153E, an MPS1 inhibitor with first-in-class potential, in adult patients with unresectable hepatocellular carcinoma (HCC) previously treated with systemic therapy

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

Abstract 4843: NMS-P293, a PARP-1 selective inhibitor with no trapping activity and high CNS penetration, possesses potent in vivo efficacy and represents a novel therapeutic option for brain localized metastases and glioblastoma

Stereoselective synthesis of 3,4‐dihydropyrrolo[1,2‐a]pyrazin‐1(2H)‐one derivatives as PIM kinase inhibitors inspired from marine alkaloids

Stereoselective synthesis of 3,4‐dihydropyrrolopyrazin‐1(2H)‐one derivatives as PIM kinase inhibitors inspired from marine alkaloids

NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies

Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure–Activity Relationships

Identification of unprecedented ATP-competitive choline kinase inhibitors

Abstract 1324: NMS-P088, a novel FLT3, KIT and CSF1R inhibitor, is a promising clinical candidate for AML and CMML treatment

Multiparametric cell cycle analysis by automated microscopy

Suchergebnisse filtern